COMMUNIQUÉS West-GlobeNewswire

-
Medicines360 acquires global rights to PeriPeach™, advancing new maternal health technology through the 360 Innovation Hub™
16/09/2025 -
Starton Therapeutics Granted New U.S. Patent #12,390,457 Titled “Stable Solutions of Immunomodulatory Imide Compounds for Parenteral Use” a Formulation of STAR-LLD
16/09/2025 -
Adial Pharmaceuticals Provides Business Update Following Favorable Comments from FDA End-of-Phase 2 (EOP2) Meeting for AD04
16/09/2025 -
CoreHealth Unveils CoreHealth NOW: A Turnkey Employee Wellness Solution for Today’s Workforce
16/09/2025 -
Marine Biologics Partners with Molecular Quantum Solutions to Accelerate Next-Generation Biomaterials Development
16/09/2025 -
Hyperion DeFi Enters Into First HAUS Agreement With Proprietary Trading Firm Credo
16/09/2025 -
SpyGlass Pharma Appoints Anand Sundaram as Head of Commercial
16/09/2025 -
HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development
16/09/2025 -
KFSHRC réduit de 75 % le temps d’attente aux urgences pour obtenir une hospitalisation
16/09/2025 -
SCIENTURE Secures PBM-Led GPO Rebate Agreement to Drive Expanded Commercial Coverage and Formulary Access for Arbli™(losartan potassium) in the $256M U.S. Losartan Market
16/09/2025 -
Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy
16/09/2025 -
Jyong Biotech Announces Completion of Patient Enrollment of over 700 subjects in Phase II Clinical Trial of MCS‑8 for Prostate Cancer Prevention
16/09/2025 -
TOMI Environmental Solutions to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2025 on September 16–17, 2025
16/09/2025 -
BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)
16/09/2025 -
PolyPid Successfully Completes Israeli Ministry of Health GMP Inspection, Advancing Towards Commercial Manufacturing Readiness for D-PLEX₁₀₀
16/09/2025 -
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Building Breakthrough Portfolio Aimed at Transforming Cancer, Rare Disease Treatments
16/09/2025 -
Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
16/09/2025 -
Commure Ambient AI Embedded in MEDITECH Expanse Now, Unlocks Seamless Mobile Documentation for Clinicians
16/09/2025 -
CytoDyn to Present at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
16/09/2025
Pages